Prapela
PrivateLast Round
Series A
Apr 22, 2025
Total Funding Raised
$8.56M
Company Overview
Prapela is a medical device company that develops and commercializes innovative stimulation therapy to improve breathing and oxygenation in newborns.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prapela Comparables
Compare Prapela with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spark Biomedical Inc | 83% | |
| smallTalk Technology, Inc. | 73% | |
| Inspiration Healthcare Group PLC | 62% | |
Prapela Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 22, 2025 | ||||
| Grant | Apr 6, 2023 | ||||
| Grant | Jun 9, 2021 | ||||
| Grant | Apr 29, 2021 | ||||
| Grant | Aug 27, 2019 | ||||
Grant | Aug 27, 2019 |
Key People
Founding team and executive leadership
Prapela Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| Alliance for Pediatric Device Innovation | Grant |
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH RADx | Grant |
| Massachusetts Life Sciences Center | Grant |
| Ohio Third Frontier | Grant |
| Maine Technology Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2023
$4M grant round led by National Institute on Drug Abuse and NIH RADx.
- Jun 9, 2021
Secured $3M from the National Institute on Drug Abuse.
Prapela Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |